Several studies and clinical trials have documented the ability of neuromodulation to reduce chronic pain in patients, therefore bringing them on the road to recovery of their quality of life.
FREMONT, CA: Studies say that around 1.2 billion adults round-the-world suffer from chronic pain that impacts their quality of life and ability to perform their day to day activities. Some patients tend to gain relief from traditional treatments, and the rest who end up unsuccessful in finding comfort in the conventional therapies rely on medical innovations.
On such medical innovation in the field of medicine is Neuromodulation, a life-changing step in providing relief to the suffering patients. Neuromodulation is known as the process of altering the nerve activity by delivering electrical currents to disrupt the pain signals that are on the way to the brain. It is achieved by a device of neuromodulation, which has precisely positioned leads linked to a power source.
The purpose of neuromodulation is to reduce the pain without any brain fog, which might result in opioids. Neuromodulation brings relief to the pain with neuro-stimulation, allowing the patients to circumvent brain fog side effects related to opioids or over-sedation. The side effects that might occur in such cases are misjudgments, fatigue, absent-mindedness, and inability to focus. Besides, neuromodulation is also administered in two different stages, which are the preliminary stage and implant stage. The short-term trial stage includes a needle-based approach through which the lead is inserted into the body. It additionally helps the patients to test the therapy before they finally consider to the implantation of the device.
Moreover, neuromodulation is an evidence-based therapy, which has displayed the reduction of chronic pain and improvement in the quality of life for many patients. Pain can be a significant factor that can hamper the ability to function as an individual and also act as a hindrance while performing the simplest day-to-day activities.
Clinical trials and extensive research have revealed that neuromodulation is an extremely low-risk treatment, which has been highly practiced, improved, and highly modernized. Neuromodulation devices have the potential to be programmed by manipulating amplitude, pulse width, and rate of electrical stimuli to boost pain relief in patients. Modern tools like neuromodulation devices also allow patients to program their devices, but it is highly recommended to check with their pain practitioner first before applying any changes. Nevertheless, the device can be removed if the patient opts to end the stop treatment and not proceed to the second stage after a successful trial.